Skip to Main Content

News

News

September 22, 2016

Charles River Laboratories and Tri-Institutional Therapeutics Discovery Institute Announce Strategic Partnership

June 16, 2016
Tri-Institutional Therapeutics Discovery Institute, Inc. Expands Partnership with Takeda Pharmaceutical Company, Ltd.

August 12, 2015
Cyclofluidic Announces Drug Discovery Agreement with the Tri-I TDI

February 2, 2015
Horizon Discovery Group Selected as Core Facility by the Tri-Institutional Therapeutics Discovery Institute

September 9, 2014
The Weill Cornell Medical College presents the MILSTEIN PROGRAM IN MEDICINAL CHEMISTRY SYMPOSIUM: FROM TARGET TO TREATMENT

December 5, 2013
Accomplished Scientist and Entrepreneur Selected to Lead Tri-Institutional Therapeutics Discovery Institute

October 1, 2013
Tri-Institutional Therapeutics Discovery Institute, Inc. Launched by Memorial Sloan-Kettering Cancer Center, The Rockefeller University and Weill Cornell Medical College, and Partnership Formed with Takeda

Press

Discovering New Therapeutics through the Power of Philanthropy
Weill Cornell Medicine

Weill Cornell profiles the Tri-I TDI in the October issue of Weill Cornell Medicine
October 14, 2015

Cultural Acclimation in New York City 
C&EN News, March 23, 2015

New agreement with Schrödinger a 'game-changer'
DDNews, October 2014

Tripling Up for Early-Stage Drug Development
Cancer Discovery, October 29, 2013

Interview with Dr. Laurie H. Glimcher
NYC Tech Connect, October 3, 2013

UES Medical Institutions to Research Life-Saving Drugs at New Facility
DNA Info, October 2, 2013

Takeda Adds Medicinal Chemistry Heft To NYC Research Partnership
The Pink Sheet Daily, October 2, 2013

 

NewsSeptember 22, 2016Charles River Laboratories and Tri-Institutional Therapeutics Discovery Institute Announce Strategic PartnershipJune 16, 2016 Tri-Institutional Therapeutics Discovery I